CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
PATTENZYME aims to enhance pharmaceutical manufacturing by developing modular 3D printed bioreactors that utilize electrochemical methods for the selective immobilization of catalysts. This innovative approach focuses on the enantioselective oxidation of omeprazole sulphide to esomeprazole, improving efficiency in acti…
The pharmaceutical industry is a major industrial sector in the EU (annual sales of €130 billion).
In contrast to other manufacturing sectors, the sector faces a significant challenge in its reliance on batch processes, with synthesis of active pharmaceutical ingredients (API) occurring via individual reaction steps.
Such an approach is not well suited to modern manufacturing methods, and reflects a gap in the state of the art in the manufacture of APIs, where flexible plug and play modular syst…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
